Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by somweyungguyon Sep 19, 2016 10:20pm

99 Views

Post# 25254414

RE:Heparin

The EAA was approved in France...so why in the world didn't they use it?

Thanks for the explanation fatfinger...are you a doctor?

If you were on the Bioniche/Telesta board Beecher could have made you another "Cowdoc"

I'm glad you choose to post here...you are quite factual and appear as tho yur legit.

Thanks Fingers,
All Thunmbs

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property